Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Pleasanton, CA
NPI: 1265742274Primary Employer
University Healthcare Alliance (Closed)
stanfordhealthcare.org
HQ Phone
Get M.D. Yasuhiro's Phone Numberphone_androidMobile
Get M.D. Yasuhiro's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2010 - 2026
CA State Medical License
2017 - 2025
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
University of Texas Health Science Center at Houston
Fellowship • Hematology and Medical Oncology
2003 - 2006
Icahn School of Medicine at Mount Sinai/Morningside/West
Residency • Internal Medicine
2000 - 2003
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 28 | 54 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 11 | 11 |
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Authors: Loretta Nastoupil, Jun Liu, Steven Horwitz, Dennis Weisenburger, Charles Butler, Mark Clemens, Kelly Hunt, Ruben Reyes, Leonard Medeiros, Rashmi Kanagal Shamanna, Ahmet Dogan, Colleen Mccarthy
Publication Date: 2016-09
Authors: Hubert Chuang, Fredrick Hagemeister, Bouthaina Dabaja, Jack Phan, Leonard Medeiros, Jason Westin, Luis Fayad
Journal: Leuk Lymphoma
Publication Date: 2013-05-07
Authors: John Plastaras, Michelle Fanale, Chelsea Pinnix, Grace Smith, Shekeab Jauhari, Bouthaina Dabaja, John Lukens, Yago Nieto
Journal: Cancer
Publication Date: 2016-12-16
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, DRUG: Romidepsin
Lead Sponsor: Curis, Inc.
Collaborators: The Leukemia and Lymphoma Society
Intervention / Treatment: DRUG: Rituximab, DRUG: venetoclax, DRUG: fimepinostat
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: Novartis
Intervention / Treatment: DRUG: AUY922